Mon. 26 Feb 2024, 1:52pm ET
Benzinga
News, Legal
BioMarin Complied With A U.S. Department Of Justice Subpoena For Documents On Its Testing Programs For VIMIZIM And NAGLAZYME; Cannot Predict Investigation's Outcome Or Its Impact On Its Business Or Financial Statements
Company Profile